BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30558966)

  • 1. Immunohistochemical analysis of c-erbB-2, Bcl-2, p53, p21
    Missaoui N; Landolsi H; Mestiri S; Essakly A; Abdessayed N; Hmissa S; Mokni M; Yacoubi MT
    Pathol Res Pract; 2019 Mar; 215(3):446-452. PubMed ID: 30558966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
    Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
    Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of Ki-67, P53 and P63 in distinguishing partial Hydatidiform mole from hydropic abortion.
    Chen Y; Shen D; Gu Y; Zhong P; Xie J; Song Q
    Wien Klin Wochenschr; 2012 Mar; 124(5-6):184-7. PubMed ID: 22218717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Analysis of E-Cadherin, p53 and Inhibin-α Expression in Hydatidiform Mole and Hydropic Abortion.
    Erol O; Süren D; Tutuş B; Toptaş T; Gökay AA; Derbent AU; Özel MK; Sezer C
    Pathol Oncol Res; 2016 Jul; 22(3):515-21. PubMed ID: 26683836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of p57, c-erbB-2, CD117, and Bcl-2 expression in the differential diagnosis of hydatidiform mole and hydropic abortion.
    Erol O; Suren D; Tutus B; Yararbas K; Sayiner A; Ozel MK; Derbent AU; Sezer C
    Eur J Gynaecol Oncol; 2016 Aug; 37(4):522-529. PubMed ID: 29894078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative activity in placentas with hydropic change and hydatidiform mole as detected by Ki-67 and proliferating cell nuclear antigen immunostaining.
    Ostrzega N; Phillipson J; Liu P
    Am J Clin Pathol; 1998 Dec; 110(6):776-81. PubMed ID: 9844590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.
    Landolsi H; Missaoui N; Brahem S; Hmissa S; Gribaa M; Yacoubi MT
    Pathol Res Pract; 2011 Aug; 207(8):498-504. PubMed ID: 21767919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.
    Lelic M; Fatusic Z; Iljazovic E; Ramic S; Markovic S; Alicelebic S
    Med Arch; 2017 Aug; 71(4):256-260. PubMed ID: 28974845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Utility of Twist1, Ki-67, and E-Cadherin in Diagnosing Molar Gestations and Hydropic Abortions.
    Moussa RA; Eesa AN; Abdallah ZF; Abdelmeged A; Mahran A; Bahaa H
    Am J Clin Pathol; 2018 Mar; 149(5):442-455. PubMed ID: 29562309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study.
    Schammel DP; Bocklage T
    Int J Gynecol Pathol; 1996 Apr; 15(2):158-66. PubMed ID: 8786206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of BCL-2 in hydatidiform moles: a tissue microarray study.
    Al-Jabri M; Al-Badi S; Al-Kindi H; Arafa M
    Pathologica; 2023 May; 1(1):148-154. PubMed ID: 37216303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressions of p53, proliferating cell nuclear antigen, and Ki-67 in gestational trophoblastic diseases.
    Uzunlar AK; Yilmaz F; Bayhan G; Akkuş Z
    Eur J Gynaecol Oncol; 2002; 23(1):79-83. PubMed ID: 11876401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
    Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of p63 in hydropic and molar gestations.
    Masood S; Kehar SI; Shawana S; Aamir I
    J Coll Physicians Surg Pak; 2015 Mar; 25(3):198-201. PubMed ID: 25772961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression.
    Cheung AN; Shen DH; Khoo US; Wong LC; Ngan HY
    J Clin Pathol; 1998 Feb; 51(2):159-62. PubMed ID: 9602692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of P63, P27, P57, Ki-67, and CD146 in hydropic and molar pregnancies.
    Balci M; Ozdemir G
    J Pak Med Assoc; 2021 Mar; 71(3):796-800. PubMed ID: 34057923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P57
    Awosusi BL; Ajani MA; Adegoke OO; Salami AA; Okolo CA
    Niger Postgrad Med J; 2020; 27(4):331-335. PubMed ID: 33154286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.